Department of Obstetrics and Gynecology, Northwestern University, Chicago, IL (Dr Dinsmoor).
Department of Obstetrics and Gynecology, George Washington University Biostatistics Center, Washington, DC (Dr Ugwu).
Am J Obstet Gynecol MFM. 2023 Apr;5(4):100874. doi: 10.1016/j.ajogmf.2023.100874. Epub 2023 Jan 20.
Maternal obesity complicates a high number of pregnancies. The degree to which neonatal outcomes are adversely affected is unclear.
This study aimed to evaluate neonatal outcomes of pregnancies complicated by maternal obesity.
This study was a secondary analysis of a cohort of deliveries occurring on randomly selected days at 25 hospitals from 2008 to 2011. Data were collected by certified abstractors. This analysis included singleton deliveries between 24 and 42 weeks of gestation. Body mass index was calculated on the basis of maternal height and most recent weight before delivery. Normal and overweight (reference group; body mass index, 18.5-29.9 kg/m), obese (body mass index, 30.0-39.9 kg/m), morbidly obese (body mass index, 40.0-49.9 kg/m), and super morbidly obese (body mass index, ≥50 kg/m) patients were compared. Patients in the reference group were matched in a 1:1 ratio with those in all other groups with obesity using the baseline characteristics of age, race and ethnicity, previous cesarean delivery, preexisting diabetes mellitus, chronic hypertension, parity, cigarette use, and insurance status. The primary outcome was composite neonatal morbidity, including fetal or neonatal death, hypoxic-ischemic encephalopathy, respiratory distress syndrome, intraventricular hemorrhage grade 3 or 4, necrotizing enterocolitis, sepsis, birth injury, seizures, or ventilator use. We used a modified Poisson regression to examine the associations between body mass index and composite neonatal outcome. Preterm delivery at <37 weeks of gestation and the presence of maternal preeclampsia or eclampsia were included in the final model because of their known associations with neonatal outcomes.
Overall, 52,162 patients and their neonates were included after propensity score matching. Of these, 21,704 (41.6%) were obese, 3787 (7.3%) were morbidly obese, and 590 (1.1%) were super morbidly obese. A total of 2103 neonates (4.0%) had the composite outcome. Neonates born to pregnant people with morbid obesity had a 33% increased risk of composite neonatal morbidity compared with those in the reference group (adjusted odds ratio, 1.33; 95% confidence interval, 1.17-1.52), but no significant association was observed for persons with obesity (adjusted odds ratio, 1.05; 95% confidence interval, 0.97-1.14) or with super morbid obesity (adjusted odds ratio, 1.18; 95% confidence interval, 0.86-1.64).
Compared with the reference group, gravidas with morbid obesity were at higher risk of composite neonatal morbidity.
母体肥胖使大量妊娠复杂化。但尚不清楚新生儿结局会受到多大程度的不利影响。
本研究旨在评估由母体肥胖引起的新生儿结局。
这是一项对 2008 年至 2011 年在 25 家医院随机选择日子分娩的队列的二次分析。数据由认证的摘要员收集。本分析包括 24 至 42 孕周的单胎分娩。基于产妇身高和分娩前的最新体重计算体重指数。正常体重和超重(参考组;体重指数 18.5-29.9kg/m)、肥胖(体重指数 30.0-39.9kg/m)、病态肥胖(体重指数 40.0-49.9kg/m)和超级病态肥胖(体重指数≥50kg/m)患者进行比较。在参考组中,根据年龄、种族和民族、既往剖宫产、既往糖尿病、慢性高血压、产次、吸烟状况和保险状况,使用基线特征,以 1:1 的比例与所有其他肥胖组患者进行匹配。主要结局是复合新生儿发病率,包括胎儿或新生儿死亡、缺氧缺血性脑病、呼吸窘迫综合征、脑室内出血 3 或 4 级、坏死性小肠结肠炎、败血症、出生损伤、癫痫发作或呼吸机使用。我们使用修正泊松回归来检查体重指数与复合新生儿结局之间的关联。由于早产(<37 孕周)和产妇子痫前期或子痫的存在与新生儿结局有关,因此将其纳入最终模型。
在倾向评分匹配后,共有 52162 名患者及其新生儿被纳入研究。其中,21704 名(41.6%)为肥胖,3787 名(7.3%)为病态肥胖,590 名(1.1%)为超级病态肥胖。共有 2103 名新生儿(4.0%)出现复合结局。与参考组相比,病态肥胖孕妇所生新生儿发生复合新生儿发病率的风险增加 33%(校正优势比,1.33;95%置信区间,1.17-1.52),但肥胖孕妇(校正优势比,1.05;95%置信区间,0.97-1.14)或超级病态肥胖孕妇(校正优势比,1.18;95%置信区间,0.86-1.64)无显著相关性。
与参考组相比,病态肥胖孕妇发生复合新生儿发病率的风险更高。